Skip to content

13F-HR filed by Opaleye Management Inc.

Opaleye Management Inc. filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 55 holding rows worth $511,320,000.

Accession
0001493152-20-021694
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 55 entries on the cover page, a total value of $511,320,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $511,320,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
OCULAR THERAPEUTIX INC67576A100COM5,984,200$45,540,000thousands by filing date
PROTARA THERAPEUTICS INC74365U107COM STK2,558,472$43,059,000thousands by filing date
ETON PHARMACEUTICALS INC29772L108COMMON STOCK3,640,000$28,756,000thousands by filing date
CARDIFF ONCOLOGY INC14147L108COM1,731,600$24,571,000thousands by filing date
ACUTUS MED INC005111109COM749,990$22,350,000thousands by filing date
CHEMOCENTRYX INC16383L106COM356,000$19,509,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM1,386,300$16,636,000thousands by filing date
HARROW INC415858109COM2,959,000$16,541,000thousands by filing date
CODEXIS INC192005106COM1,400,000$16,436,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock315,550$15,945,000thousands by filing date
VAXCYTE INC COM92243G108Stock313,000$15,456,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW992,000$14,711,000thousands by filing date
MACROGENICS INC556099109COM527,000$13,275,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM222,000$11,389,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK3,021,436$10,817,000thousands by filing date
APTOSE BIOSCIENCES INC COM03835T200Stock1,799,000$10,794,000thousands by filing date
AVENUE THERAPEUTICS INC05360L205COM984,692$10,664,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock390,000$10,436,000thousands by filing date
TRACON PHARMACEUTICALS INC89237H209COM NEW2,013,438$10,409,000thousands by filing date
FORTRESS BIOTECH INC34960Q109COM3,830,000$10,264,000thousands by filing date
MYOVANT SCIENCES LTDG637AM102COMMON STOCK-FO682,500$9,589,000thousands by filing date
CHIMERIX INC COM16934W106Stock3,841,500$9,565,000thousands by filing date
SERES THERAPEUTICS INC81750R102COM335,312$9,493,000thousands by filing date
AXOVANT SCIENCES LTDG0750W203COM2,039,100$9,421,000thousands by filing date
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A338,000$8,778,000thousands by filing date
XOMA ROYALTY CORPORATION98419J206COMMON STOCK455,000$8,572,000thousands by filing date
CERECOR INC15671L109COM3,372,500$7,678,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM114,350$7,434,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM1,487,800$6,130,000thousands by filing date
FIBROGEN INC31572Q808COM147,000$6,045,000thousands by filing date
TELA BIO INC872381108COM362,074$5,989,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM470,203$5,863,000thousands by filing date
MEI PHARMA INC55279B202COM NEW1,556,000$4,855,000thousands by filing date
EDAP TMS S A268311107SPONSORED ADR1,040,000$4,784,000thousands by filing date
CYTOKINETICS INC23282W605COM NEW208,800$4,521,000thousands by filing date
CRINETICS PHARMACEUTICALS INC COM22663K107Stock240,000$3,761,000thousands by filing date
FULCRUM THERAPEUTICS INC359616109COMMON STOCK452,000$3,584,000thousands by filing date
LUMOS PHARMA INC55028X109COM240,892$3,329,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM678,000$3,282,000thousands by filing date
VERASTEM INC92337C104COM2,200,000$3,201,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock970,664$2,766,000thousands by filing date
AEGLEA BIOTHERAPEUTICS INC00773J103COM375,000$2,659,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock767,400$2,440,000thousands by filing date
OUTSET MEDICAL INC690145107COM45,000$2,250,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW271,350$1,872,000thousands by filing date
SUTRO BIOPHARMA INC869367102COM146,000$1,467,000thousands by filing date
CONTRAFECT CORP212326300COM226,127$1,194,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM100,000$982,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW225,000$947,000thousands by filing date
X4 Pharmaceuticals, Inc.98420X103COM75,000$508,000thousands by filing date
ONCTERNAL THERAPEUTICS INC68236P107COM194,541$331,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM145,000$300,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM3,171,800$137,000thousands by filing date
NULL09071M205NULL16,667$33,000thousands by filing date
MERUS N VN5749R100COM200$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-20-021694this filing2020-11-16acceptance time not in the bulk data set